NCT02599571终止不适用
Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers
Duke University4 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2016年3月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 71
- 试验地点
- 4
- 主要终点
- Composite measure of outcomes associated with acceptability; withdrawal measured by the MNWS and compliance measured by Time-Line Follow-Back questionnaire and daily self-report cigarette use
研究概览
简要总结
The purpose of this study is to investigate the impact of different nicotine levels in cigarettes with individuals who have ADHD.
详细描述
The purpose of this study is to examine the effects of very low nicotine content (VLNC) cigarettes on smoking behavior, psychiatric symptoms and functioning, and acceptability and adverse outcomes in young adult smokers with ADHD. Participants will attend a screening session, 2 baseline sessions, 6 experimental sessions, and a 30 day follow-up visit. Participants will be asked to smoke only the study cigarettes that we provide for 6 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 18 - 40
- •Smoke an average of 5-40 cigarettes per day for at least 1 year
- •Breath CO levels > 8 ppm (if ≤ 8 ppm, then NicAlert Strip > 6)
- •Primary diagnosis of ADHD, any subtype as assessed by the CAADID; T-Score > 65 on one of the DSM- V relevant scales (Inattentive Symptoms, Hyperactive-Impulsive Symptoms, Total Symptoms or ADHD Index) on the Self-Report version of the CAARS; Clinician Rated ADHD-RS score >
- •Cognitive functioning > 80 as assessed by the KBIT-II
排除标准
- •Intention to quit smoking in the next 30 days
- •Currently seeking treatment for smoking cessation
- •Currently using nicotine replacement therapies or other pharmacotherapies as cessation aid (intermittent use acceptable)
- •A quit attempt in the past 30 days resulting in greater than 3 days of abstinence
- •Using other tobacco products more than 9 days in the past 30 days
- •Significant unstable medical conditions (any significant change in a serious medical condition occurring during the past 3 months including cardiovascular disease, COPD, and cancer, as determined by the study physician at each site)
- •Significant unstable psychiatric conditions (any significant change in psychiatric symptoms during the past 3 months as determined by the study physician at each site)
- •Any Axis I Psychiatric Disorder as assessed by the MINI that is significantly impairing and/or would contraindicate participation in the study
- •Psychiatric medication changes in the past 3 months including new prescriptions, changes in dosages or discontinuation of medications
- •Positive toxicology screen for any of the following drugs: cocaine, opiates, methadone, benzodiazepines, barbiturates, amphetamines, methamphetamines, and PCP (Marijuana will be tested for but will not be an exclusionary criterion, participants with valid prescriptions for opiates, benzodiazepines, barbiturates, amphetamines or methadone will not be excluded, participants failing the toxicology screen will be allowed to re-screen once. These participants will need to be re-consented before being rescreened to ensure they have received adequate informed consent.)
- •Breath alcohol level > 0.01 (Participants failing the breath alcohol screen will be allowed to re-screen once. These participants will need to be re-consented before being rescreened to ensure they have received adequate informed consent.)
- •Current diagnosis of DSM alcohol or drug use disorder (except for nicotine)
- •Pregnant, trying to become pregnant or breastfeeding
- •Smoking 'roll your own cigarettes' exclusively
- •Currently taking anticonvulsant medications including: Phenytoin [Brand Name: Dilantin], Carbamazepine [Brand Name: Tegretol, Carbatrol, Equetro, Epitol], Oxcarbazepine [Brand Name: Trileptal], Primidone [Brand Name: Mysoline], Phenobarbital
- •CO reading >80 ppm
- •Systolic BP between 90 and 160 (If below 90 then asymptomatic. Participants failing for blood pressure will be allowed to re-screen once.)
- •Diastolic BP between 50 and 100 (If below 50 then asymptomatic. Participants failing for blood pressure will be allowed to re-screen once.)
- •Heart rate between 45 and 115 bpm (If below 45 then asymptomatic. Participants failing for heart rate will be allowed to re-screen once.)
- •Indicating any suicidal ideation in the past month or suicide attempts in the past 10 years.
- •Inability to independently read and comprehend the consent form and other written study materials and measures.
- •Having participated in a research study during the past three months in which the participant: Smoked a cigarette that was not his/her usual brand cigarette for more than one day, used any tobacco products beyond normal use for more than one day, used any nicotine replacement products or smoking cessation medications for more than one day
- •Any previous experience using SPECTRUM cigarettes
结局指标
主要结局
Composite measure of outcomes associated with acceptability; withdrawal measured by the MNWS and compliance measured by Time-Line Follow-Back questionnaire and daily self-report cigarette use
时间窗: Six weeks
Composite of study dropout, compliance, changes in physical health
Number of cigarettes smoked per day
时间窗: Six weeks
Self-reported number of cigarettes smoked per day
Composite measure of influence of reduced nicotine content on ADHD symptoms measured by ADHD Rating Scale and Clinical Global Impressions Scale along with related measures of cognition measured by the N-Back Task and the Continuous Performance Test
时间窗: Six weeks
Composite of ADHD symptom questionnaires, inhibitory control, working memory
次要结局
- Measures of other health-related behaviors; dependence measures(Six weeks)
- Measures of discomfort/dysfunction; withdrawal and depression(Six weeks)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic StatusTobacco DependenceNCT01928719Milton S. Hershey Medical Center280
已完成
不适用
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent SmokersNicotine DependenceNCT02587312Brown University70
已完成
不适用
Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety DisordersTobacco DependenceNCT01928758Milton S. Hershey Medical Center245
已完成
不适用
Very-Low Nicotine Cigarettes and Non-Daily SmokersSmokingNCT02228824Saul Shiffman312
已完成
不适用
Switching to Reduced Oxidant or Nicotine Content Cigarettes in SmokersTobacco Smoking BehaviorNCT02415270Milton S. Hershey Medical Center37